Evidence map›Paper›PMID 24879660›Full record

ArticleVeterinary pathology2015

Ultrastructural abnormalities of the trabecular meshwork extracellular matrix in Cyp1b1-deficient mice.

L B C Teixeira, Y Zhao, R R Dubielzig, C M Sorenson, N Sheibani

Open access · greenAbstract read
In one paragraph

Article in Veterinary pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Insights intoLife (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Exploring the Genetic Landscape of Childhood Glaucoma.Children (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Challenges and Opportunities in P450 Research on the Eye.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  9. Article
  10. Geographical Variability inJournal of clinical medicine · 2022
    Review
  11. Review
  12. Novel compound heterozygous mutations inMolecular medicine reports · 2021
    Article
  13. Article
  14. NullInternational journal of molecular sciences · 2021
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

L B C TeixeiraDepartment of Pathobiological Sciences, School of Veterinary Medicine, Madison, WI, USA McPherson Eye Research Institute, University of Wisconsin, Madison, WI, USA lteixeira@wisc.edu.
Y ZhaoDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, USA.
R R DubielzigDepartment of Pathobiological Sciences, School of Veterinary Medicine, Madison, WI, USA McPherson Eye Research Institute, University of Wisconsin, Madison, WI, USA.
C M SorensonMcPherson Eye Research Institute, University of Wisconsin, Madison, WI, USA Department of Pediatrics, University of Wisconsin, Madison, WI, USA.
N SheibaniMcPherson Eye Research Institute, University of Wisconsin, Madison, WI, USA Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, USA.
Smith-Kettlewell Eye Research Institute · USUniversity of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI ROBERT W NICKELLS · 2005 to 2026
$12.6M
Novel Antiangiogenic Peptides for Treatment of Exudative AMDR24EY022883 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI SHEIBANI, NADER · 2013 to 2017
$6.2M
Integrated Multidisciplinary Strategies for Detection of Diabetic RetinopathiesRC4EY021357 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI ASSADI, AMIR H, ASSADI-PORTER, FARIBA M · 2010 to 2010
$3.2M
CYP1B1 and Retinopathy of PrematurityR01EY018179 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI SHEIBANI, NADER · 2009 to 2010
$713k
NCI NIH HHS P30 CA014520NEI NIH HHS EY016995NEI NIH HHS EY018179NEI NIH HHS P30 EY016665NEI NIH HHS P30-EY016665NEI NIH HHS R01 EY018179NEI NIH HHS R24 EY022883NEI NIH HHS RC4 EY021357
6 · The paper itself

Abstract

Cytochrome P450 1B1 (CYP1B1) is highly expressed in human and murine ocular tissues during development. Mutations in this gene are implicated in the development of primary congenital glaucoma (PCG) in humans. Mice deficient in Cyp1b1 (Cyp1b1(-/-) ) present developmental abnormalities similar to human primary congenital glaucoma. The present work describes the ultrastructural morphology of the iridocorneal angle of 21 eyes from 1-week-old to 8-month-old Cyp1b1(-/-) mice. Morphometric and semiquantitative analysis of the data revealed that 3-week-old Cyp1b1(-/-) mice present a significantly (P < .005) decreased amount of trabecular meshwork (TM) collagen and higher TM endothelial cell and collagen lesion scores (P < .005) than age-matched controls. Collagen loss and lesion scores were progressively increased in older animals, with 8-month-old animals presenting severe atrophy of the TM. Our findings advance the understanding of the effects of CYP1B1 mutations in TM development and primary congenital glaucoma, as well as suggest a link between TM morphologic alterations and increased intraocular pressure.

Indexed as

AnimalsCytochrome P-450 CYP1B1Disease Models, AnimalExtracellular MatrixFemaleGlaucomaHumansMiceMice, KnockoutMutationOxidative StressTrabecular MeshworkCyp1b1 protein, mouseCytochrome P-450 CYP1B1collagen fibrilscongenital glaucomaCYP1B1electron microscopyeyemouseoxidative stresstrabecular meshwork

Identifiers

PMID24879660
PMCPMC4285769
OpenAlexW2153741862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.